Discover 1,443 paid clinical trials in Everett, Washington. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,443
Active & Responsive
Advancing Transplantation Outcomes in Children
for
Kidney Transplant
Location: Seattle WA, Vancouver, Los Angeles CA, Aurora CO,
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Sex: All
Age: 13 - 20
Code: NCT06055608
Phase 2, Recruiting
Active & Responsive
Follow-up Automatically vs. As-Needed Comparison (FAAN-C) Trial
Location: Seattle WA, Salt Lake City UT, Mountain View CA,
Sponsor: University of Utah
Sex: All
Age: 0 - 18
Code: NCT05471908
Recruiting
Active & Responsive
MANATEE-T1D: Metformin ANd AutomaTEd Insulin Delivery System Effects on Renal Vascular Resistance, Insulin Sensitivity, and Cardiometabolic Function in Youth With Type 1 Diabetes
for
Type 1 Diabetes, Diabetic Kidney Disease,
Location: Seattle WA
Sponsor: Kalie Tommerdahl
Sex: All
Age: 12 - 25
Code: NCT05065372
Phase 1, Recruiting
Active & Responsive
Outcomes in Pediatric and Young Adult B-Cell Malignancies After Commercially Available Immunotherapy
for
Lymphoid Leukemia
Location: Seattle WA, Portland OR, San Francisco CA, Palo Alto CA,
Sponsor: Stanford University
Sex: All
Age: 0 - 26
Code: NCT05865301
Recruiting
Active & Responsive
Slow Heart Registry of Fetal Immune-mediated High Degree Heart Block
for
Heart Block Complete, Heart Block Second Degree
Location: Seattle WA, San Francisco CA, Denver CO, Phoenix AZ,
Sponsor: The Hospital for Sick Children
Sex: Female
Age: 16 - 50
Code: NCT04559425
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
Hemoglobin Maintenance in Pediatric ESRD (End-stage Renal Disease) Patients by Ferric Pyrophosphate Citrate (FPC)
for
End Stage Renal Disease
Location: Seattle WA, Loma Linda CA, Kansas City MO,
Sponsor: Rockwell Medical Technologies, Inc.
Sex: All
Age: 0 - 17
Code: NCT04239391
Phase 3, Recruiting
Active & Responsive
Long-Term Follow-Up of Subjects Treated With Seattle Children's Therapeutics Gene Therapy Products
for
CAR T Cell, CAR T Cell Therapy
Location: Seattle WA
Sponsor: Seattle Children's Hospital
Sex: All
Age: 0+
Code: NCT07424157
Recruiting
Active & Responsive
A Randomized Phase 1/2 Trial of Low Dose Anti-thymocyte Globulin (ATG) With Subsequent Adalimumab or Verapamil in New Onset Type 1 Diabetes
for
Type 1 Diabetes, New Onset
Location: Seattle WA, San Francisco CA, Minneapolis MN,
Sponsor: City of Hope Medical Center
Sex: All
Age: 9 - 20
Code: NCT07061574
Phase 1, Phase 2, Recruiting
Active & Responsive
NEPTUNE Match Study
for
Nephrotic Syndrome in Children,
Location: Seattle WA, Spokane WA, Kansas City KS, Kansas City MO,
Sponsor: University of Michigan
Sex: All
Age: 1 - 70+
Code: NCT04571658
Recruiting
Active & Responsive
EPIK-P4: A Phase II Single-arm Study to Assess the Efficacy, Safety and Pharmacokinetics of Alpelisib (BYL719) in Pediatric and Adult Patients With PIK3CA-related Overgrowth Spectrum (PROS)
for
PIK3CA-related Overgrowth Spectrum (PROS)
Location: Seattle WA, Portland OR, Sacramento CA, St Louis MO,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 2 - 70+
Code: NCT06997588
Phase 2, Recruiting
Active & Responsive
Restarting Triple Therapy With Robust Monitoring for Adverse Events (RETRIAL)
for
Cystic Fibrosis
Location: Seattle WA, Denver CO, Aurora CO, Kansas City KS,
Sponsor: Boston Children's Hospital
Sex: All
Age: 6+
Code: NCT06683092
Recruiting
Active & Responsive
Effects of High-Resistance Inspiratory Muscle Strength Training on Cardiorenal and Vascular Function in Youth and Young Adults With Type 2 Diabetes
for
Diabetes Mellitus Type 2
Location: Seattle WA
Sponsor: Seattle Children's Hospital
Sex: All
Age: 14 - 40
Code: NCT06936670
Recruiting
Active & Responsive
High vs.Standard Dose Influenza Vaccine in Pediatric Solid Organ Transplant (SOT) Recipients
Location: Seattle WA, Los Angeles CA, Fountain Valley CA,
Sponsor: Fresenius Kabi
Sex: All
Age: 0 - 17
Code: NCT06274788
Recruiting
Active & Responsive
A Phase 2 Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, in Adults and Children With PIK3CA Related Overgrowth Spectrum and Malformations Driven by PIK3CA Mutation (The ReInspire Study)
for
PIK3CA-Related Overgrowth Spectrum (PROS),
Location: Seattle WA, San Francisco CA, Palo Alto CA,
Sponsor: Relay Therapeutics, Inc.
Sex: All
Age: 2+
Code: NCT06789913
Phase 2, Recruiting
Active & Responsive
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
for
NASH - Nonalcoholic Steatohepatitis,
Location: Seattle WA, Vancouver WA, Edmonton, Folsom CA,
Sponsor: Akero Therapeutics, Inc
Sex: All
Age: 18 - 70+
Code: NCT06528314
Phase 3, Recruiting
Active & Responsive
A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis
for
NASH With Fibrosis, MASH With Fibrosis
Location: Seattle WA, Spokane WA, Edmonton, Reno NV, Folsom CA,
Sponsor: Akero Therapeutics, Inc
Sex: All
Age: 18 - 70+
Code: NCT06215716
Phase 3, Recruiting
Active & Responsive
A Study to Assess How Well and Safely Elafibranor Works in Adult Participants With Primary Sclerosing Cholangitis
for
Primary Sclerosing Cholangitis
Location: Seattle WA, San Francisco CA, Pasadena CA, Englewood CO,